Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings
Status:
Not yet recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to determine whether insulin glargine reduces the risk
of serious hypoglycemia or improves Time in Range at 6 months when compared against standard
of care human insulin (e.g. NPH or premixed 70/30) among youth living with type 1 diabetes
(T1D) in low resource settings.
Phase:
Phase 4
Details
Lead Sponsor:
Jing Luo
Collaborator:
The Leona M. and Harry B. Helmsley Charitable Trust